Clinical Trial Update: RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA [Phase 1, Phase 2]

View source ↗

Summary

A stratified Phase I/II trial (RADVAX) assessing hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma has completed enrollment with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-08-10